MAPT and tauopathy: To test if the Tau4R-GFP biosensor can report the in vivo progression of tauopathy, we emulated intracerebral injection methods that induce (prion-like) Tau pathology in mice (Clavaguera et al., 2013; Guo et al., 2016; Peeraer et al., 2015).